| Donald L Bowser, NP | |
|
520 Medical Center Dr, Suite 100, Medford, OR 97504-4334 | |
| (541) 789-5704 | |
| (541) 789-5989 |
| Full Name | Donald L Bowser |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 520 Medical Center Dr, Medford, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023165925 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 080046081N3ANP-PP (Oregon) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donald L Bowser, NP 520 Medical Center Dr, Suite 100, Medford, OR 97504-4334 Ph: (541) 789-5704 | Donald L Bowser, NP 520 Medical Center Dr, Suite 100, Medford, OR 97504-4334 Ph: (541) 789-5704 |
News Archive
If you smoke, drink more than two units of alcohol a day, are underweight, don't exercise or eat well, you could be setting yourself up for osteoporosis later in life, according to a new report issued by the International Osteoporosis Foundation (IOF).
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology , announced today that it has raised $2.3 million in a private placement of promissory notes from two accredited U.S. investors. The promissory notes, due on or before August 4, 2010, are repayable at NexMed's option in either cash or shares of unregistered common stock at prices ranging from $0.36 to $0.40 per share.
The current science and experience does not support the safety and efficaciousness of a biosimilar pathway for plasma protein therapies. At a public hearing last week, the Plasma Protein Therapeutics Association (PPTA) urged the United States Food and Drug Administration (FDA) to make patient safety its top priority by adopting a global approach in its evaluation of plasma protein therapies for the biosimilars process.
The multiple "litter" births of mice, versus the normal singleton pregnancy of humans, is due to defective processing in mice of a common mammalian protein called bone morphogenetic protein 15 (BMP-15), according to new research from the University of California, San Diego (UCSD) School of Medicine.
A new presentation today at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Expo in Chicago- focused on the health benefits of short-chain fructooliogosaccharides (scFOS), which are low-calorie, non-digestible carbohydrates that can improve food taste and texture while aiding immunity, bone health and the growth and balance of important bacteria in the digestive track.
› Verified 6 days ago
Helen Koenigsman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1333 E Barnett Rd, Medford, OR 97504 Phone: 541-779-4711 | |
Dr. Todd S Kotler, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 520 Medical Center Drive, Ste 200, Medford, OR 97504 Phone: 541-282-6606 Fax: 541-282-6601 | |
Dr. Mark G Moran, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 520 Medical Center Drive, Ste 200, Medford, OR 97504 Phone: 541-282-6606 Fax: 541-282-6601 | |
Dr. June Symens, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 555 Black Oak Dr Ste 400, Medford, OR 97504 Phone: 541-821-6090 | |
Samridhi Amba, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 827 Spring St, Medford, OR 97504 Phone: 541-732-7600 | |
Margaret Sara Fairhurst, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1698 E Mcandrews Rd Ste 400, Medford, OR 97504 Phone: 541-732-7960 |